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Abstract 
Methylglyoxal is an endogenous metabolite that increases in diabetes and has been implicated in some of its long-term complications 
such as retinopathy, neuropathy and cataract. We investigated the reaction of methylglyoxal with isolated human and bovine lens 
crystallins (cy, &, &_ and y). After 7 days incubation at 37°C and pH 6.9, the reaction of methylglyoxal with lens proteins yielded 
stable adducts that exhibited fluorescent properties. SDS-polyacrylamide gel electrophoresis was used to monitor aggregation and 
crosslinking of the modified protein and autoradiography showed that [14C]methylglyoxal was incorporated into all the protein bands. 
Bovine y-crystallin was the most reactive towards methylglyoxal. Reaction of methylglyoxal with bovine y II-crystallin, which is found 
mainly in the lens nucleus, could alter the charge surface network of the molecule, resulting in aggregation, increased light scattering and 
hence cataract. Modification of -yII-crystallin by methylglyoxal produced an overall loss of positive charge and an increase in molecular 
weight and non-disulfide covalent crosslinking. Amino acid analysis of the modified yII-crystallin showed a loss of 47% of arginine 
residues. 
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1. Introduction 
Methylglyoxal (Zoxopropanal) is a biological metabo- 
lite formed by the non-enzymatic and enzymatic degrada- 
tion of triose phosphates, dihydroxyacetone phosphate and 
glyceraldehyde-3-phosphate. Other sources include 
aminoacetone and hydroxyacetone, products of threonine 
catabolism and acetone metabolism respectively [ll. The 
glyoxalase system, using reduced glutathione as a cofactor, 
catalyzes the conversion of methylglyoxal to D-lactate via 
the intermediate S-D-lactoylglutathione. 
Thornalley et al. have shown that the system is modi- 
fied in hyperglycemia, which may be linked to the devel- 
opment of diabetic complications [2]. The concentration of 
methylglyoxal increased in cultured human red blood cells 
during hyperglycemia and increased levels of methylgly- 
oxal were found in blood from diabetic patients [3] and in 
the lens of rats made diabetic by injection of streptozotocin 
[41. 
Methylglyoxal is a reactive compound which covalently’ 
binds to lysozyme, introducing crosslinking and fluores- 
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cence similar to the Maillard reaction (non-enzymic 
browning) [5]. Van der Jagt showed that glucose and 
methylglyoxal reacted with albumin to produce modified 
proteins with new absorption and emission bands that were 
spectrally similar and that methylglyoxal was much more 
reactive than glucose [6]. Methylglyoxal has also been 
shown to inhibit the activity of red blood cell Na,K-ATPase 
[7] and of some glycolytic enzymes 181. It reacted mainly 
with arginine and lysine residues of proteins [9-111. 
Diabetes is a powerful risk factor for cataract, espe- 
cially in females [12]. The cataracts in older diabetic 
patients do not appear to have any specific morphology but 
seem to be part of a multifactorial mechanism leading to 
lens opacification [13]. Human lens contains, by weight, 
about 35% protein [14], the bulk of this being crystallin 
structural protein [El. The rate of protein turnover in lens 
fibre cells is very low and thus the proteins are susceptible 
to environmental insults over decades. Post-translational 
modification of lens protein has been shown to result in 
conformational changes, crosslinking and aggregation of 
proteins leading to lens opacification [15]. This is the first 
report on the in vitro binding of methylglyoxal to isolated 
human and bovine lens crystallins ( CX, &, , & and y 1. 
Modification by methylglyoxal resulted in the formation of 
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stable adducts which showed new fluorescent properties. 
Crosslinking of protein was monitored by SDS-polyacryl- 
amide gel electrophoresis. 
Bovine -y-crystallin was the most reactive towards meth- 
ylglyoxal. A detailed study of the reaction of methylgloxal 
with one of the y-crystallins, bovine y II-crystallin, which 
is found mainly in the lens nucleus, was undertaken. The 
complete amino acid sequence of y II-crystallin is known 
[16,17] and its crystal structure has been determined [18]. 
The surface of 711 is largely polar and hydrophillic and 
contains several arginine residues. By binding to arginine 
residues on the surface of the molecule, methylglyoxal 
may affect the overall charge distribution of the molecule, 
causing altered interaction with adjacent molecules and 
aggregate formation. 
2. Materials and methods 
2.1. Chemicals 
Methylglyoxal was provided by Dr. Thomalley, pre- 
pared by methods described [19]. The concentration of the 
aqueous solution was determined by endpoint assay in- 
volving conversion to S-D-lactoylglutathione with glyox- 
alase I and hydrolysis catalyzed by glyoxalase II following 
the method of MacLellan et al. [20]. [2-‘4C]Methylglyoxal 
was from Dr. Thornalley, prepared by methods described 
[21]. Sephacryl S300 High Resolution was from Pharmacia 
(Milton Keynes, Bucks., UK). Hyperfilm-MP autoradiog- 
raphy film was from Amersham (Little Chalfont, Bucks.). 
Unless otherwise indicated, reagents were of the highest 
quality obtainable from Sigma (Poole, Dorset, UK) or 
BDH (Poole, Dorset, UK). 
2.2. Lenses 
Bovine eyes were obtained fresh from the local abattoir. 
The lenses were dissected out and stored at - 20°C until 
use. Intact human cataract lenses were provided by Dr. 
R.M. Broekhuyse (University of Nijmegen, The Nether- 
lands). 32 lenses (5 grade I cataractous, and 27 grade II, 
according to the Pirie grading system [22]), were used to 
isolate the human crystallins. 
2.3. Isolation of human and bovine lens crystallins 
Seven bovine lenses and 32 human cataractous lenses 
were separated by gel filtration on a Sephacryl S300HR 
column (97 cm X 7 cm i.d.) according to the method of 
Slingsby and Bateman [23]. Fractions corresponding to 
each protein peak (a, /3n, & and -y> were dialysed 
against four changes of distilled water, freeze-dried and 
stored at -20°C. Protein purity was assayed using SDS- 
polyacrylamide gel electrophoresis using the method given 
below. 
2.4. Incorporation of [‘4C]methylglyoxal into isolated 
bovine and human crystallins 
Unless otherwise indicated all incubations were carried 
out in 0.1 M sodium phosphate buffer, pH 6.9, containing 
0.05% NaN, to prevent bacterial growth. To determine the 
rate of incorporation of methylglyoxal into isolated bovine 
crystallins, incubations were set-up containing final con- 
centrations of 2 mg ml-’ of (Y, &, pi_ or y-crystallin 
respectively and 5 mM methylglyoxal (4.5 @Zi of 
[ l4 C]methylglyoxal diluted with the unlabelled compound) 
in a total volume of 3 ml. For the human crystallins, 
incubations were set-up containing final concentrations of 
2 mg ml- ’ of (Y, /3n, & or y-crystallin respectively and 
5 mM methylglyoxal (1.0 &i of [14C]methylglyoxal di- 
luted with the unlabelled compound) in a total volume of 3 
ml. Control incubations were set up containing the isolated 
human or bovine crystallins ((Y, Pn, & and r> in buffer 
alone. Another control incubation contained 5 mM methyl- 
glyoxal in buffer. In a separate experiment, incubations 
were set-up to monitor incorporation into bovine y-crystal- 
lin (2 mg ml-‘) at lower concentrations of methylglyoxal 
(3 mM and 0.3 mM). 
The solutions were filtered through 0.2 pm-pore size 
Nalgene filters into sterile vials and incubated at 37°C in a 
shaking water bath for 7 days. Aliquots (3 X 20 ~1) were 
removed at zero time using a sterile needle and syringe to 
estimate the total radioactivity in the incubation. Every 24 
h, 3 X 50 ~1 aliquots were removed and incorporation of 
label into trichloroacetic acid precipitable protein was de- 
termined as described by Crompton et al. [24]. Results 
were calculated as moles of methylglyoxal bound per mole 
of polypeptide (taking into account the dilution by unla- 
belled methylglyoxal and assuming an average polypeptide 
mass of 20 kDa for the protein). Aliquots were removed 
after 0 and 7 days incubation for SDS-polyacrylamide gel 
electrophoresis. 
2.5. Addition of sodium borohydride to modified isolated 
human crystallins 
Sodium borohydride, which reduces and thus stabilises 
Schiff bases, was added to aliquots of the incubating 
solution to ascertain whether any methylglyoxal was bound 
as a Schiff-base to the protein. 1 h before the end of the 7 
day incubation, 3 X 50 ~1 aliquots were removed from the 
incubating solutions of human crystallins and placed in 
Eppendorf tubes. Sodium borohydride was dissolved in 0.1 
M sodium phosphate buffer (pH 6.9, 0.05% NaN,) to 
make a 215 mM solution, from which 50 ~1 was immedi- 
ately removed and added to each Eppendorf tube. After 1 h 
the reaction was stopped by the addition of 1 ml of 10% 
(w/v) trichloroacetic acid. The tubes were left overnight at 
4°C. The number of mol of methylglyoxal bound per mole 
of polypeptide was determined. 
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2.6. Aggregation of isolated bovine and human lens crys- 
tallins monitored by SDS-polyactylamide gel electrophore- 
sis 
mg ml-l with incubation buffer for spectrofluorirnetric 
analysis. 
After 7 days of incubation of the bovine and human 
crystallins with methylglyoxal, 0.2 ml of each solution was 
centrifuged in a Millipore Ultra-filter (molecular cut-off; 
10 kDa) at 2800 X g for 10 min until the protein solution 
was reduced to approx. 40 ~1. 100 ~1 of distilled water 
was added to the Ultra-filters and the tubes were cen- 
trifuged for a further 7 min. This served to concentrate the 
protein and remove any salts and unreacted methylglyoxal. 
100 ~1 of loading buffer was added and the solutions were 
vortexed and stored at - 20°C until they were run on a 
12.5% gel. The same procedure was followed for the 
control incubations (isolated bovine and human crystallins 
incubated in buffer alone and for crystallins dissolved in 
buffer that had not been incubated. 
Analysis of tryptophan fluorescence used an exciting 
wavelength of 280 nm, recording emission spectra from 
300 to 500 nm. Non-tryptophan fluorescence used an 
exciting wavelength of 320 nm, recording emission from 
340-500 nm. Emission spectra were obtained using a 
Perkin Elmer Luminescence Spectrometer LS50 (emission 
and excitation slit widths 5.0 nm; scan speed 240 nm 
min-‘1. 
2.10. Isolation of y-crystallin 
Bulk preparation of y-crystallin was carried out using a 
Sephadex G-50 column (fine beaded) according to the 
method of Martin and Harding [26]. y-Crystallin purity 
was tested by SDS-polyacrylamide gel electrophoresis 
(single band at 20 kDa). 
2.7. SDS-polyacrylamide gel electrophoresis 2.11. Isolation of yII-ciystallin 
This method is based on that of Laemmli [25]. The 
protein samples were boiled in the loading buffer (63 mM 
Tris buffer, pH 6.8, containing 2% (w/v) sodium dodecyl- 
sulfate, 5% (v/v> mercaptoethanol, 10% (w/v> glycerol 
and 0.01% (w/v) Bromophenol blue) for 5 min prior to 
electrophoresis. SDS-polyacrylamide gel electrophoresis 
was performed using an LKB 2052 Midget Electrophoresis 
unit, 12.5% slab gels and 5% stacking gels. Standard 
proteins were run with each gel; bovine serum albumin 66 
kDa, egg albumin 45 kDa, thermolysin 37.5 kDa, carbonic 
anhydrase 29 kDa and lysozyme 14 kDa. The gels were 
run at 40 mA constant current. Protein bands were visual- 
ized by Coomassie Brilliant Blue staining (1.25%) and 
destained in methanol/acetic acid/water (50:10:40, v/v>. 
The y-crystallins were separated according to the method 
of Bjiirk [28], except a SP-Sephadex C-50 column (84 
cm X 1.8 cm i.d.) was used instead of a SE-Sephadex C-50 
column. The y II-crystallin obtained gave a single band by 
SDS-polyacrylamide gel electrophoresis and a single peak 
on HPLC under conditions given below. 
2.12. Modification of yII-crystallin by methylglyoxal and 
elution from a cation exchange column 
2.8. Autoradiography 
The gel containing [ I4 Clmethylglyoxal-modified bovine 
crystallins was dried onto filter paper using a LKB 2003 
slab gel drier unit. Autoradiography was carried out using 
autoradiography film (Hyperfilm MP) with a 21 day expo- 
sure. 
2.9. Spectrofluorimetric analysis 
Experimental incubations were set-up containing final 
concentrations of 2 mg ml-’ of bovine cu, /ln, & or 
y-crystallin with 5 mM methylglyoxal in a final volume of 
3 ml. Control incubations were set-up without methylgly- 
oxal. After 7 days the solutions were dialysed against two 
changes of distilled water (2 X 2 1) and 2 changes of 
incubation buffer (2 X 1.5 1) to remove any unreacted 
methylglyoxal. The protein concentrations of the dialysed 
solutions were determined using the Bradford method. The 
solutions were diluted to a protein concentration of 0.25 
y II-Crystallin (17.1 mg) was dissolved in the incuba- 
tion buffer containing 5 mM methylglyoxal to a final 
concentration of 4 mg ml-‘. The solution was sterile 
filtered into a sterile vial and incubated at 37°C in a 
shaking water bath for 24 h. The reaction was stopped by 
dialysis against three changes of distilled water (2 1) and 
three changes of 0.2 M sodium acetate buffer pH 5.0 (1.5 
1) over 48 h. The protein solution was then eluted from the 
same cation exchange column as described previously. The 
methylglyoxal modified protein eluted as a single peak. 
The fractions corresponding to this peak were pooled and 
extensively dialysed against distilled water (seven changes 
including one overnight dialysis) then freeze-dried. 12.5 
mg of an off-white solid was recovered. This product was 
analysed by HPLC and SDS-polyacrylamide gel elec- 
trophoresis. 
2.13. Aggregation monitored by HPLC 
The methylglyoxal-modified y II-crystallin (2 mg ml- ’ ) 
and a sample of unmodified yII-crystallin (2 mg ml-‘) 
were dissolved in elution buffer (0.1 M sodium phosphate, 
pH 6.6, containing 0.1 M sodium sulfate). The samples 
were filtered through 0.22 pm Millipore filter units. 10 ~1 
samples were injected onto a TSK G3000 SWXL size 
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exclusion column and eluted with elution buffer (which 
had been filtered and degassed) at a flow rate of 1 ml/min. 
The absorbance was measured at 280 nm on a Gilson UV 
detector. The column was calibrated with standards. 
2.14. Aggregation monitored by SDS-polyacrylamide gel 
electrophoresis 
The methylglyoxal-modified y II-crystallin (2 mg ml - ’ ) 
and a sample of unmodified y II-crystallin (2 mg ml-’ ) 
were boiled in loading buffer before being run on a 12.5% 
SDS-polyacrylamide gel as described previously. 
2.15. Amino acid analysis 
The methylglyoxal-modified y II- (2 mg ml-‘> and 
unmodified y II-crystallin (2 mg ml-‘) were dissolved in 6 
M HCI and hydrolysed in vacua for 18 h at 108-110°C. 
The acid was removed by rotary evaporation and the 
hydrosylate was analysed using the Waters Pico.Tag 
method (Millipore Corporation, Waters Chromatography 
Division, MA, USA) based on a method by Heinrikson 
and Meredith [27]. The hydrolysed protein samples were 
derivatised with phenylisothiocyanate then separated by 
reverse phase HPLC using an octadecylsilane CODS) col- 
umn. The phenylthiocarbamyl amino acids eluted were 
detected at 254 nm on a Gilson UV detector over 25 min. 
3. Results 
3.1. Incorporation of [‘4C]methylglyoxal into isolated 
bovine and human crystallins 
The incorporation of label was monitored for seven 
days. Fig. 1A and B shows the incorporation of 5 mM 
[ l4 Clmethylglyoxal into bovine and human crystallins. 
Bovine crystallins appear more susceptible to modification 
than human crystallins, but all the major crystallin frac- 
tions of both species react with methylglyoxal. Fig. 1C 
shows the incorporation of lower concentrations of 
[‘4C]methylglyoxal (3 mM and 0.3 mM) into bovine y- 
crystallin. 
3.2. Effect of sodium borohydride on methylglyoxal-mod- 
ified human crystallins 
Sodium borohydride reduces and stabilises Schiff-base 
adducts. There was no significant change in the number of 
mol of bound methylglyoxal to human (Y, & or &-crys- 
tallin after addition of NaBH,. The number of moles of 
methylglyoxal bound to human y-crystallin increased by 
15.7% after reduction with sodium borohydride (P < 0.05, 
Student’s t-test). 
3.3. Aggregation of bovine lens proteins 
Fig. 2A shows the SDS-polyacrylamide gel of bovine 
crystallins ((Y, &, & and 7) isolated from the Sephacryl 
S300 HR column. No change was observed after incuba- 
tion of the crystallins in buffer for 7 days (Fig. 2B). Fig. 
2C shows the results obtained after bovine crystallins (a, 
/3n, & and -y> had been incubated in 5 mM methylgly- 
oxal for 7 days. The bands of the modified crystallins all 
appear more diffuse. Both (Y- and y-crystallins show an 
apparent increase in molecular mass from approx. 20 to 29 
kDa. Aggregated bands are present with each modified 
crystallin with an apparent molecular mass of approx. 45 
to 55 kDa. Bands are also present between the stacking gel 
and the running gel with the modified (Y, & and &- 
crystallins due to precipitated protein. Similar results were 
obtained for the human lens proteins except for the ab- 
sence of an aggregated y-crystallin band after modification 
by methylglyoxal (Fig. 2D, E and F>. 
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Fig. 1. Incorporation of [‘4C]methylglyoxal into isolated (A) bovine lens 
crystallins and (B) human crystallins: N, y; v, cr; v &; 0, &; (C) 
incorporation of 3 mM (v ) and 0.3 mM ( V) [‘4C]methylglyoxal into 
bovine ycrystallins. All points were calculated from the mean of tripli- 
cate determinations + SD. Error bars for the lowest curve are too small to 
be seen. 






Fig. 2. SDS-PAGE of (A) unmodified bovine crystallins, (B) bovine 
crystallins incubated in buffer for 7 days, (C) bovine crystallins incubated 
in 5 mM methylglyoxal for 7 days, (D) unmodified human crystallins, (E) 
human crystallins incubated in buffer for 7 days, (F) human crystallins 
incubated in methylglyoxal for 7 days. Lanes: (2) (Y, (3) &, (4) &, (5) 
y. Molecular weight standards were run in lanes (1) and (6) and were the 
same in each gel. 
3.4. Autoradiography 
Autoradiography of the dried gel containing bovine 
crystallins, modified with [ l4 Clmethylglyoxal showed that 
the label had been incorporated into all the crystallin 
fractions and also into the aggregated bands (Fig. 3). 
2 3 4 5 
Fig. 3. Autoradiography of the gel shown in Fig. 2C, corresponding to 
lanes 2 to 5. 
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Fig. 4. Tryptophan fluorescence spectra (ex. 280 mn, em. 300-500 nm) 
of (1) (r, (2) &, (3) &, (4) ycrystallin. Spectra are presented for 
crystallins incubated in 5 mM methylglyoxal for 7 days (lower curve) and 
crystallins incubated in buffer alone (upper curve). (B) Non-tryptophan 
fluorescence spectra (ex. 320 nm, em. 340-500 mu) of (1) (Y, (2) &, (3) 
&, (4) y-crystallin. Spectra are presented for crystallins incubated in 5 
mM methylglyoxal for 7 days (upper curve) and crystallins incubated in 
buffer alone (lower curve). 
3.5. Changes in jluorescence after modification by methyl- 
glyoxal 
Excitation of isolated lens proteins at 280 nm yielded 
tryptophan fluorescence with an emission maximum at 
approx. 335 nm which did not change significantly after 7 
days incubation. Incubation of the isolated crystallins with 
methylglyoxal resulted in a decrease in tryptophan fluores- 
cence with (Y-, &,- and &-crystallin (Fig. 4A). Decreased 
quantum yields have usually been associated with the 
chromophore being in a more polar environment, e.g., 
more surface exposed. When excited at 280 mn, methyl- 
glyoxal-modified y-crystallin yielded a second emission 
maximum at 385 nm. Methylglyoxal incubated alone as a 
control produced little fluorescence after excitation at 280 
nm. 
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Fig. 5. Elution profiles from a SP-Sephadex C-50 cation exchange 
column (a) of y-crystallins (~11 to yIV1, (b) of methylglyoxal-modified 
y II-crystallin. 
Incubation of the individual crystallins with methylgly- 
oxal resulted in non-tryptophan fluorescence in all cases 
(ex. 320 nm; em. 340-500 nm) with an emission maxi- 
mum at approx. 390 nm (Fig. 4B). The greatest increase in 
non-tryptophan fluorescence was produced by methylgly- 
oxal modified y-crystallin. Lens crystallins ((Y, &, & 
and 7) incubated alone and methylglyoxal incubated alone 
produced little fluorescence after excitation at 320 nm. 
3.6. Isolation of yZZ-crystallin 
The Sephadex G-50 elution profile for bovine lens 
soluble protein gave two main peaks and was similar to 
that obtained by Martin and Harding [26]. SDS-polyacryl- 
amide gel electrophoresis showed the first peak to be a 
mixture of (Y- and P-crystallins and the second peak to be 
y-crystallin (gel not shown). 
The SP-Sephadex C-50 cation exchange column allows 
separation of the y-crystallins (~11 to y IV). The elution 
profile is shown in Fig. 5 (elution profile a) and is similar 
to that obtained by Bjijrk [28]. The three fractions were run 
on an SDS-polyacrylamide gel and corresponded to a 
molecular mass of about 20 kDa (gel not shown). The 
fractions were analysed by electrospray mass spectrometry. 
The ESMS of II-crystallin gave a mass of 20969 kDa 
which agrees exactly with the sequence [17] and that 
obtained previously by ESMS [29]. The methylglyoxal- 
modified y II-crystallin eluted from the same cation-ex- 
change column in the void volume, as a single peak (Fig. 
5, elution profile b). 
3.7. Aggregation of methylglyoxal-modified yZZ-crystallin 
monitored by HPLC 
To study the crosslinking and aggregation, y II-crystal- 
lin was incubated with 5 mM methylglyoxal for 24 h. At 
0 5 10 15 
Hetentiun Time (minutes) 
Fig. 6. HPLC chromatogram of (a) unmodified bovine y II-crystallin, (b) 
methylglyoxal-modified y II-crystallin. (Inset) Calibration standard curve 
using molecular weight markers; bovine serum albumin 66 kDa, egg 
albumin 45 kDa, thermolysin 37.5 kDa, carbonic anhydrase 29 kDa, 
y II-crystallin 21 kDa and lysozyme 14 kDa. 
this time 76% of the maximum reaction should have 
occurred (Fig. 1A). Chromatograms of methylglyoxal- 
modified y II-crystallin and unmodified y II-crystallin are 
shown in Fig. 6. y II-Crystallin eluted as a single peak 
after 15.1 min (elution profile a). The modified sample 
eluted after 11.9 min (elution profile b), indicating that 
methylglyoxal had caused aggregation of all the protein. 
The molecular weight of the modified protein was esti- 
mated at 35.5 kDa from the calibration curve (Fig. 6, 
inset). 
3.8. Aggregation of methylglyoxal-modified yZZ-crystallin 
monitored by SDS-polyacrylamide gel electrophoresis 
Fig. 7 shows an SDS-polyacrylamide gel of methylgly- 
oxal-modified y II-crystallin and of unmodified y II-crys- 
1 2 3 
Fig. 7. SDS-PAGE. Lanes: (21 unmodified yI1 (20 &, (3) methylgly- 
oxal-modified ~11 (20 pg). Molecular weight standards were run in lane 
(1). 
42 M.L. Riley, J.J. Harding/Biochimica et Biophysics Acta 1270 (1995) 36-43 
Table 1 
Amino acid Amino acid composition (residues/molecule) 
calculated y Ikrystallin methylglyoxal-modified 
y II-crystallin 
ASP 19 12.8 15.6 
Glu 19 17.5 21.2 
Ser 13 15.0 15.8 
Gly 14 17.2 17.1 
His 5 5.4 5.4 
Thr 5 5.6 5.8 
kg 20 20.1 a 9.3 
Ala 2 2.7 
Pro 8 8.7 8.9 
Tyr 15 15.5 14.2 
Val 6 6.1 6.3 
Met 7 7.5 9.9 
Ile 6 8.4 8.2 
LeU 13 12.7 12.7 
Phe 9 9.0 8.7 
LYs 2 1.9 1.7 
Results shown are the mean of duplicate determinations. 
a Arg and Ala residues coeluted. 
tallin. For the modified sample there is an apparent in- 
crease in molecular weight of the major band from 20 kDa 
to approx. 2.5 kDa and the appearance of a faint aggregated 
band at approx. 48 kDa. This faint band is due to non-dis- 
ulfide covalent cross-linking, since mercaptoethanol (which 
breaks disulfide bonds) was present in the loading buffer. 
Comparing Figs. 6 and 7 it appears that dimerization of all 
the protein (as seen in Fig. 6) is due to non-covalent 
binding because the SDS-gel indicates that only a small 
proportion of the protein is covalently crosslinked. 
3.9. Determination of yll-crystallin residues modified by 
methylglyoxal 
The results obtained from amino acid analysis of 7 II- 
crystallin are similar to the theoretical values calculated 
from the published sequence [17]. After modification by 
methylglyoxal there was a loss of 47% of arginine residues 
(Table 1). Tryptophan and cysteine were not determined 
due to loss during acid hydrolysis and derivitization, re- 
spectively. 
4. Discussion 
Diabetes is an established risk factor for cataract. Work 
has been published suggesting that non-enzymic glycosyla- 
tion (glycation) of lens proteins may be involved in 
cataractogenesis and other diabetic complications [30]. Re- 
action of lens proteins with glucose and glucose-6-phos- 
phate was first reported by Stevens et al. [31]. The authors 
suggested that glycation altered the conformation of pro- 
teins thus promoting disulfide crosslinking and aggrega- 
tion. 
Methylglyoxal also increases in diabetes and reacts 
much more rapidly than glucose with proteins [6], so its 
impact in vivo might be greater than its low concentration 
would suggest. The concentrations of methylglyoxal used 
in our experiments were much higher than those found 
physiologically [20], but cataract develops over years or 
decades. Methylglyoxal has been shown to bind to plasma 
proteins under physiological conditions (1 PM) [ll]. 
Our experiments show that methylglyoxal will readily 
form adducts with the major human and bovine lens 
proteins, resulting in a possible alteration in the tertiary 
structure of the protein, detected by a decrease in trypto- 
phan fluorescence of the modified samples compared with 
the controls. The adducts formed exhibit non-tryptophan 
fluorescence (ext. 320 nm; em. 340-500 nm). Similar 
changes were observed for glycated a-crystallin compared 
with non-glycated a-crystallin, isolated from human dia- 
betic lenses [32]. 
Reaction with methylglyoxal resulted in aggregation 
and non-disulfide covalent crosslinking of lens crystallins 
similar to changes that occur during the formation of 
cataract in man [13]. Reduction of the modified bovine 
crystallins with sodium borohydride indicated that only 
y-crystallin had reacted to form a Schiff-base with methyl- 
glyoxal and this accounted for only 13.5% of the total 
amount of methylglyoxal bound. The y-crystallins have a 
free terminal a-amino group which, in yII-crystallin, has 
been shown to react with fructose [33]. However, since the 
human crystallins were isolated from grade I and grade II 
cataractous lenses, it is likely that they had already suf- 
fered some post-translational modifications. 
An overall loss of positive charge of methylglyoxal- 
modified y II-crystallin was demonstrated by its increased 
elution rate from a cation exchange column. Amino acid 
analysis of modified y II-crystallin showed arginine 
residues to be the major site of reaction. Modification of 
an arginine residue would result in the loss of a positive 
charge, which could disrupt the surface network of charges 
of y II-crystallin and destabilize its native conformation. 
The charge network is thought to be very important for 
stability [34]. Aggregation and crosslinking of modified 
protein was shown by HPLC and SDS-polyacrylamide gel 
electrophoresis. 
Many of these changes that have been shown to occur 
in vitro with glucose, fructose, glucose-6-phosphate, glu- 
cosamine and ribose [13]. During cataractogenesis it is 
possible to envisage several metabolites with reactive alde- 
hyde groups acting in an additive or synergistic manner. 
Diabetic cataracts probably have multifactorial origins and 
non-enzymic post-translational modification of proteins 
most likely is involved in cataractogenesis. 
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